Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System

Medicine & Life Sciences

1. Tumor-Infiltrating Lymphocytes 100%
2. Gastrointestinal Neoplasms 93%
3. Clustered Regularly Interspaced Short Palindromic Repeats 90%
4. Research Ethics Committees 83%
5. Genes 31%